Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

Creative Commons License

Mascherbauer J., Marzluf B. A., Tufaro C., Pfaffenberger S., Graf A., Wexberg P., ...More

CIRCULATION-CARDIOVASCULAR IMAGING, vol.6, no.6, pp.1056-1065, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 6
  • Publication Date: 2013
  • Doi Number: 10.1161/circimaging.113.000633
  • Journal Name: CIRCULATION-CARDIOVASCULAR IMAGING
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1056-1065
  • Keywords: hypertension, pulmonary, magnetic resonance imaging, prognosis, DIFFUSE MYOCARDIAL FIBROSIS, EUROPEAN-SOCIETY, HYPERTROPHIC CARDIOMYOPATHY, PULMONARY-HYPERTENSION, SYSTOLIC FUNCTION, RISK-FACTORS, TASK-FORCE, ECHOCARDIOGRAPHY, DYSFUNCTION, COLLAGEN
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Background The underlying pathophysiology of heart failure with preserved ejection fraction (HFPEF) is incompletely understood, but myocardial extracellular matrix accumulation is thought to play a major role. Our aims were to estimate myocardial extracellular matrix using cardiac magnetic resonance T1 mapping and to assess the relationship between pathobiology/pathophysiology and prognosis.